Home › Sarcoidosis › NCT01745237
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
RecruitingObservational study
Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Biopsy proven sarcoidosis * Suspected cardiac sarcoidosis Exclusion Criteria: * Contraindication to MRI
About the study
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Sponsor: Duke University · Participants: 27,000 · Started: 2002-09
Contact the study team
- Han W Kim, MD · Phone: 919-668-3539
- Raymond J. Kim, MD · Phone: 919-668-3539
Official record on ClinicalTrials.gov — NCT01745237
Locations in the U.S.
| North Carolina | Duke University Medical Center, Durham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.